Table 1. Characteristics of the 240... | American Society of Hematology

Table 1.

Characteristics of the 240 Eligible Patients at Study Entry

Characteristic	GM-CSF Group (N = 114)		Placebo Group (N = 126)		P Value
Characteristic	No.	%	No.	%	P Value
Median age (yr)	66		66.5		.30^*
Age group (yr)
55-64	50	44	55	44	.54^-151
65-75	64	56	71	56
Sex (male/female)	58	56	69	57	.55^-151
Performance status
0-1	79	69	87	69	.84^-151
2-3-4	35	31	39	31
FAB classification
M0	10	9	10	8	.80^-151
M1	30	26	43	34
M2	29	25	30	24
M3	5	4	2	2
M4	20	18	20	16
M5	14	12	13	10
M6	5	4	5	4
M7	0	0	1	1
Unclassified	1	1	2	2
White blood cell count (/μL)
<30,000	86	75	93	74	.88^-151
>30,000	28	25	33	26
Hemoglobin median value (g/dL)	9.2		9		.16^*
Median platelet count (×1,000/μL)	69		62		.27^*
Cytogenetic analysis
Missing
Not done	12	11	14	11	.83^-151
Not assessable	22	19	28	22
Normal	41	36	44	35
Abnormal
Favorable	6	5	4	3
Intermediate	14	12	17	13
Unfavorable	19	17	19	15

Characteristic	GM-CSF Group (N = 114)		Placebo Group (N = 126)		P Value
Characteristic	No.	%	No.	%	P Value
Median age (yr)	66		66.5		.30^*
Age group (yr)
55-64	50	44	55	44	.54^-151
65-75	64	56	71	56
Sex (male/female)	58	56	69	57	.55^-151
Performance status
0-1	79	69	87	69	.84^-151
2-3-4	35	31	39	31
FAB classification
M0	10	9	10	8	.80^-151
M1	30	26	43	34
M2	29	25	30	24
M3	5	4	2	2
M4	20	18	20	16
M5	14	12	13	10
M6	5	4	5	4
M7	0	0	1	1
Unclassified	1	1	2	2
White blood cell count (/μL)
<30,000	86	75	93	74	.88^-151
>30,000	28	25	33	26
Hemoglobin median value (g/dL)	9.2		9		.16^*
Median platelet count (×1,000/μL)	69		62		.27^*
Cytogenetic analysis
Missing
Not done	12	11	14	11	.83^-151
Not assessable	22	19	28	22
Normal	41	36	44	35
Abnormal
Favorable	6	5	4	3
Intermediate	14	12	17	13
Unfavorable	19	17	19	15

*Student's t test.

Chi-square test or Fisher's exact test when appropriate.